ACCEPt defeat? No way, says lead investigator of general practice chlamydia screening trial
Criticism of an Australian general practice chlamydia screening trial, which failed to show that opportunistic testing reduced infection prevalence, has been rejected by the lead researcher.
Professor Jane Hocking, from the University of Melbourne, has rebutted claims in a Lancet editorial that the three-year Australian Chlamydia Control Effectiveness Pilot (ACCEPt) study was poorly conducted.
The randomised controlled trial — the largest of its kind in the world — involved 1200 GPs from 54 rural towns in NSW, Victoria